Induction of Clinical Autoimmune Disease by Therapeutic Interferon-α

References

• Isaacs, A. and Lindenman, J. (1987) "Virus interference. I. The interferon", J. Interferon Res. 7, 429–438
   PubMedGoogle Scholar
• Cacoub, P. and Benhamou, Y. (2002) "Role of interferons in the treatment of hepatitis B and C virus infections", Rev. Med. Interne 23, 457–474
   Google Scholar
• Chander, G., Sulkowski, US., Jenckes, MW., Torbenson, US., Herlong, H.F., Bass, E.B. and Gebo, K.A. (2002) "Treatment of chronic hepatitis C: a systematic review", Hepatology 36, S135—S144
   Web of Science ®Google Scholar
• O'Duffy, J.D., Calamia, K., Cohen, S., Goronzy, J.J., Herman, D., Jorizzo, J., Weyand, C. and Matteson, E. (1998) "Interferon-a treatment of Behcet's disease", J. Rheumatol. 25, 1938–1944
   PubMed Web of Science ®Google Scholar
• Zeller, V., Cohen, P., Nguyen, Q.T., Lebon, P., Dziri, S., Ferriere, F., Deny, P. and Guillevin, L. (2002) "Intravenous interferon-a treatment of mixed cryoglobulinemia associated with chronic hepatitis C virus infection", Clin. Exp. Rheumatol. 20, 573–574
   PubMed Web of Science ®Google Scholar
• Kalidas, M., Kantarjian, H. and Talpaz, M. (2001) "Chronic myelogenous leukemia", JAMA 286, 895–898
   PubMed Web of Science ®Google Scholar
• Lacotte-Thieny, L. and Guilhot, F. (2002) "Intereferons and haematology", Rev. Med. Interne 23, 481s–488s
   Google Scholar
• Group, M.T.C. (2001), Br J. Haematol. 113, 1020–1034
   Google Scholar
• Mey, U., Strehl, J., Gorschluter, M., Ziske, C., Glsmacher, A., Pralle, H. and Schmidt-Wolf, I. (2003) "Advances in the treatment of hairy-cell leukemia", Lancet Oncol. 4, 86–94
   PubMed Web of Science ®Google Scholar
• Kirkwood, J. (2001) "Cancer immunotherapy: the interferon-a experince", Semin. Oncol. 29, 18–26
   Google Scholar
• Oberg, K. (2001) "Chemotherapy and biotherapy in the treatment of neuroendocrine tumours", Ann. Oncol. 12(2), S111 —S114
   Google Scholar
• Fattovich, G., Giustina, G., Favarato, S. and Ruol, A. (1996) "A survey of adverse vents in 11,241 patients with chronic viral hepatitis treated with alfa interferon", J. Hepatol. 24, 38–47
   PubMed Web of Science ®Google Scholar
• Okanoue, T., Sakamoto, S., Itoh, Y., Minami, M., Yasui, K., Sakamoto, M., et al. (1996) "Side effects of high-dose interferon therapy for chronic hepatitis, C", J. Hepatol. 24, 283–291
   Web of Science ®Google Scholar
• Kirkwood, J.M., Bender, C., Agarwala, S., Tarhini, A., Shipe-Spotloe, J., Smelko, B., Donnelly, S. and Stover, L. (2002) "Mechanisms and manangement of toxicities associated with high-dose interferon alfa 2b therapy", J. Clin. Oncol. 20, 3703–3718
   PubMed Web of Science ®Google Scholar
• Wandl, U.B., Nagel-Hiemke, M., May, D., Kreutzfelder, E., Kloke, O., Kranzhoff, M., Seeber, S. and Niederle, N. (1992) "Lupus-like autoimmune disease induced by interferon therapy for myelo-proliferative disorders", Clin. Immunol. Immunopathol. 65, 70–74
   PubMedGoogle Scholar
• Quesada, J.R., Talpaz, M., Rios, A., Kurzrock, R. and Gutterman, J.U. (1986) "Clinical toxicity of interferons in cancer patients: a review", J. Clin. Oncol. 4, 234–243
   PubMed Web of Science ®Google Scholar
• Ioannou, Y. and Isenberg, D. (2000) "Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy", Arthritis Rheum. 43, 1431–1442
   PubMed Web of Science ®Google Scholar
• Ronnblom, L.E., Alm, G.V. and Oberg, K.E. (1991) "Autoimmunity after a interferon therapy for malignant carcionoid tumors", Ann. Intern. Med. 115, 178–183
   PubMed Web of Science ®Google Scholar
• Valenti, G., Mantelli, A., Persico, M., Tuccillo, C., Del Vechio Blanco, G., Morisco, F., et al. (1999) "Serologic and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions", Clin. Exp. Rheumatol. 17, 75–79
   PubMed Web of Science ®Google Scholar
• Clifford, B.D., Donahue, D., Smith, L., Cable, E., Luttig, B., Maims, M., et al. (1995) "High prevalence of serologic markers of autoimmunity in patients with chronic hepatitis", C. Hepatol. 21, 613–619
   Google Scholar
• Reddy, KR., Krawitt, E., Radick, J., Chastenay, B., de Medina, M., Jeffers, L.J., Parker, T., et al. (1993) "Absence of LKM1 antibody in hepatitis C viral infection in the United States (abstract)", Hepatology 18, 173A
   PubMed Web of Science ®Google Scholar
• Czaja, A.J., Carpenter, H., Santrach, P.J., Moore, S.B., Taswell, H.F. and Homburger, RA. (1993) "Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States", J. Hepatol. 18, 342–352
   PubMed Web of Science ®Google Scholar
• Hooks, J.J., Moutsopoulos, H.M., Geis, S.A., Stahl, NJ., Decker, J.L. and Notkins, Al. (1979) "Immune interferon in the circulation of patients with autoimmune disease", N. Engl. J. Med. 301, 5–8
   PubMed Web of Science ®Google Scholar
• Ytterberg, S.R. and Schnitzer, T. (1982) "Serum interferon levels in patients with systemic lupus erythematosus", Arthritis Rheum. 25, 401–406
   PubMed Web of Science ®Google Scholar
• Ronnblom, L.E. and Alm, G.V. (2003) "Systemic lupus erythematosus and type I interferon system", Arthritis Res. Then 5, 68–75
   PubMed Web of Science ®Google Scholar
• Ehrenstein, MR., McSweeny, E., Swane, M., Worman, CP., Goldstone, AR and Isenberg, D.A. (1993) "Appearance of anti-DNA antibodies in patients treated with Interferon alfa", Arthritis Rheum. 36, 279–280
   PubMedGoogle Scholar
• Kalkner, KM., Ronblom, L, Karlsson Parra, AK., Bengtsson, M., Olsson, Y. and Oberg, K. (1998) "Antibodies against double-stranded DNA and developement of polymyositis during treatment with interferon", QJM 91, 393–399
   PubMedGoogle Scholar
• Ronnblom, L.E., Alin, G.V. and Oberg, K.E. (1991) "Autoimmunity after « interferon therapy for malignant carcionoid tumors", Ann. Intern Med. 115, 178–183
   PubMed Web of Science ®Google Scholar
• Sacchi, S., Kantarjian, H., O'Brien, S., Cohen, P.R., Pierce, S. and Talpaz, M. (1995) "Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia", J. Clin. Oncol. 13, 2401–2407
   Google Scholar
• McCarthy, D.J., Manzi, S. and Medsger, TA., Jr. (1995) "Incidence of systemic lupus erythematosus. Race and gender differences", Arthritis Rheum. 38, 1260
   PubMedGoogle Scholar
• Wilson, L.E., Widman, D., Daman, S.H. and Gorevic, P.D. (2002) "Autoimmune disease complicating antiviral therapy for hepatitis C virus infection", Semin. Arthritis Rheum. 32, 163–173
   PubMed Web of Science ®Google Scholar
• Stastny, P. (1978) "Association of B-cell alloantigen DRw4 with rheumatoid arthritis", N. Engl. J. Med. 298, 869–871
   PubMed Web of Science ®Google Scholar
• Shiozawa, S., Chihara, K. and Shiozawa, K. (1986) "A sensitive radioimmunoassay for alfa interferon: circulating alfa interferon like substance in the plasma of healty individuals and RA patients", Clin. Exp. Immunol. 66, 77–87
   PubMed Web of Science ®Google Scholar
• Shiozawa, S., Shiozawa, K., Kita, M., Kishida, T., Fujita, T. and Imuar, S. (1992) "A preliminary report on the effect of alfa-interferon treatment on the joint inflammation and serum calcium in rheumatoid arthritis", Br. J. Rheumatol. 31, 405–408
   PubMedGoogle Scholar
• Ardicoglu, O., Koseoglu, F. and Koka, I. (1993) "Lack of effect of recombinant alfa interferon in the treatment of rheumatoid arthritis", Scand. J. Rheumatol. 22, 204–205
   PubMed Web of Science ®Google Scholar
• Levesque, MC., Ward, FE., Jeffrey, D.R. and Weinberg, LB. (1999) "Interferon beta induced polyarthritis in a patient with the HLA-DRB1*0404 allele", Arthritis Rheum. 42, 569–573
   PubMed Web of Science ®Google Scholar
• Nesher, G. and Ruchlemer, R. (1998) "Alpha-interferon -induced arthritis: clinical, presentation, treatment and prevention", Semin. Arthritis Rheum. 27, 360–365
   PubMed Web of Science ®Google Scholar
• Chan, G.C., Lee, S.S. and Yeah, E.K. (1992) "Monoarthritis in a chronic hepatitis B patient after « interferon treatment", J. Gastroenterol. Hepatol. 7, 432–433
   PubMed Web of Science ®Google Scholar
• Lombardini, F., Taglione, E., Riente, L. and Pasero, G. (1997) "Psoriatic arthritis with spinal involvement in a patient receiving «-interferon for chronic hepatitis C", Scand. J. Rheumatol. 26,58–63
   PubMed Web of Science ®Google Scholar
• Weiland, C.M. and Goronzy, J.J. (1997) "Pathogenesis of rheumatoid arthritis", Med. Clin. North Am. 81, 29–55
   PubMed Web of Science ®Google Scholar
• De Maeyer, E. and De Maeyer-Guignard, J. (1998) "Type I interferons", Int. Rev. Immunol. 17, 53–73
   PubMedGoogle Scholar
• Passos de Souza, E., Teles Evangelista Secundo, P., Freire Jose, F., Lemaire, D. and Santiago, M. (2001) "Rheumatoid arthritis induced by ck-Interferon therapy", Clin. Rheumatol. 20, 297–299
   PubMed Web of Science ®Google Scholar
• Hartmann, F.V., Wussow, P. and Deicher, H. (1989) "Psoriasis-Exazerbation bei therapie mit a-interferon", Dtsch. Med. Wschr. 114, 96–98
   PubMed Web of Science ®Google Scholar
• Nguyen, C., Misery, L., Tigaud, J.D., Petiot, A., Fiere, D., Fuare, M. and Claudy, A. (1996) "Psoriasis induced by interferon-a. Apropos of a case", Ann. Med. Interne 147, 519–521
   PubMedGoogle Scholar
• Shiohara, T., Kobayshi, M., Kimiaki, A. and Nagashima, M. (1988) "Psoriasis occuring predominantly on warts", Arch. Dennatol. 124, 1816 —1821
   Google Scholar
• Taylor, C., Burns, D.A. and Wiselka, M.J. (2000) "Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C", Postgrad. Med. J. 76, 365–366
   PubMed Web of Science ®Google Scholar
• Rahamimov, R., Klaus, S. and Tur-Kaspa, R. (1994) "Psoriasis is not a contraindication for « interferon treatment in patients with chronic hepatitis C", Acta Dennato-Venereol. (Stockh) 75, 86
   Web of Science ®Google Scholar
• Pauluzzi, P., Kokelj, F., Perkan, V., Pozzato, G. and Moretti, M. (1993) "Psoriasis exacerbation induced by interferon—alfa. Report of two cases", Acta Dennato-Venereol. (Stockh) 73, 395
   PubMed Web of Science ®Google Scholar
• Georgetson, M.J., Yarze, J.C., Labs, AT., Webster, G.F. and Martin, P. (1993) "Exacerbation of psoriasis due to interferon—a treatment of chronic active hepatitis", Am. J. Gastroenterol. 88, 1756–1758
   PubMed Web of Science ®Google Scholar
• Erkek, E., Karaduman, A., Akcan, Y, Sokmensuer, C. and Bukulmez, G. (2000) "Psoriasis associated with HCV and exacerbated by interferon ck: complete clearance with acitretin during interferon a treatment for chronic active hepatitis", Dermatology 201, 179–180
   PubMed Web of Science ®Google Scholar
• Garcia-Lora, E., Tercedor, J., Massare, E., Lopez-Nevot, MA., Skiljo, M. and Garcia-Mellado, V. (1993) "Interferon-induced psoriasis in a patient with chronic hepatis C", Dermatology 187, 280
   PubMed Web of Science ®Google Scholar
• Wolfe, IT., Singh, A., Lessin, SR., Jaworsky, C. and Rook, A.H. (1995) "De nova developement of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma", J. Am. Acad. Dennatol. 33, 887–893
   PubMed Web of Science ®Google Scholar
• Matsuoka, H., Uno, H., Nakama, N., Maeda, K. and Tsubouchi, H. (1994) "Psoriasis exacerbated by a-interferon therapy in a case of chronic myelogenous leukemia (abstract)", Rinsho Ketsueki 35, 309–311
   PubMedGoogle Scholar
• Neumann, R., Pohl-Markl, H. and Aberer, E. (1987) "Parenteral interferon—a treatment of psoriasis", Dennatologica 175, 23–28
   PubMedGoogle Scholar
• Moller, D.R. (1997) "Etiology of sarcoidosis", Clin. Chest Med. 18, 695–706
   PubMed Web of Science ®Google Scholar
• Pietropaoli, A., Modrak, J. and Utell, M. (1999) "Interferon-« therapy associated with the developement of sarcoidosis", Chest 116, 569–571
   PubMed Web of Science ®Google Scholar
• Hoffmann, R.M., Jung, M-C., Motz, R., Gobl, C., Emslander, H-P., Zachoval, R. and Pape, G.R. (1998) "Sarcoidosis associated with interferon-a therapy for chronic hepatis C", J. Hepatol. 28, 1058–1063
   PubMed Web of Science ®Google Scholar
• Fiorani, C., Sacchi, S., Bonacorsi, G. and Cosenza, M. (2000) "Systemic sarcoidosis associated with interferon-a treatment for chronic myelogenous leukemia", Haematologica 85, 1006–1007
   PubMed Web of Science ®Google Scholar
• Nawras, A., Alsolaiman, MM., Mehboob, S., Bartholomew, C. and Maliakkal, B. (2002) "Systemic sarcoidosis presenting as a granulomatous tatoo reaction secondary to interferon-« treatment for chronic hepatitis C and review of literature", Dig. Dis. Sci. 47, 1627 —1631
   PubMed Web of Science ®Google Scholar
• Tahan, V., Ozseker, F., Guneylioglu, D., Baran, A., Ozaras, R., Men, A., Ucisik, AC., Cagatay, T., Yilmazbayhan, D. and Senturk, H. (2003) "Sarcoidosis after use of interferon for chronic hepatitis C", Dig. Dis. Sci. 48, 169–173
   PubMed Web of Science ®Google Scholar
• Vander Els, N.J. and Gerdes, H. (2000) "Sarcoidosis and 1FN-ee treatment", Chest 117, 294
   PubMedGoogle Scholar
• Wendling, J., Descamps, V., Grossin, M., et al. (2002) "Sarcoidosis during combined interferon « and ribavirin therapy in 2 patients with chronic hepatitis C", Arch. Dennatol. 138, 546–547
   Google Scholar
• Cleveland, M.G. and Mallory, S.B. (1993) "Incomplete Reiter's syndrome induced by systemic interferon treatment", J. Am. Acad. Dennatol. 29, 788–789
   PubMed Web of Science ®Google Scholar
• Schapira, D., Nahir, A.M. and Hadad, N. (2002) "Interferon-induced Raynaud's Syndrome", Semin. Arthritis Rheum. 32, 157–162
   PubMed Web of Science ®Google Scholar
• Lee, S-W., Kim, K-C., Oh, D-H., Jung, S-S., Yoo, D-H., Kim, S.Y., Choe, G. and Kim, T-H. (2002) "A case of polymyositis with dilated cardiomyopathy associated with interferon « treatment for hepatitis B", J. Korean Med. Sci. 17, 141–143
   PubMed Web of Science ®Google Scholar
• Piqueras Alcol, B., de Diego Lorenzo, A., Perez Roidan, F., Banos Diaz, E. and Clemente Ricote, G. (1996) "Interferon-a and developement of psoriatic arthropathy", An. Med. Intema. 13, 512–513
   PubMedGoogle Scholar
• Ryas, W., Myers, D., Mann, R. and Seraly, M.P. (1999) "Remission of psoriasis after treatment with interferon-alfa and 2-chlordeoxyadeno-sine for hairy cell leukemia", J. Am. Acad. Dennatol. 40, 316–318
   Google Scholar
• Downs, A.M. and Dunnill, M.G. (2000) "Exacerbation of psoriasis by interferon-a therapy for hepatitis", Clin. Exp. Dennatol. 25,351–352
   PubMedGoogle Scholar
• Jucgla, A., Marcoval, J., Curco, N. and Servitje, O. (1991) "Psoriasis with articular involvement induced by interferon alfa", Arch. Dennatol. 127, 910–911
   Google Scholar
• Olivieri, I., Padula, A., Ciancio, J. and La Civita, L. (2001) "Psoriatic arthritis and ck-interferon", Scand. J. Rheumatol. 30, 175
   PubMed Web of Science ®Google Scholar
• Germain, P., Delbrel, X., Traissac, T., Etienne, G., Lacoste, D., Le Bras, M. and Longy-Boursier, M. (1999) "Rhumatisme psoriatique sous interferon « reversible a l'arret du traitment", Presse Med. 28, 2226–2227
   PubMedGoogle Scholar
• Spadero, A., Riccieri, V., Nisi, A. and Taccari, E. (1993) "IgM rheumatoid factor occurence with recurrence of polyarthritis and psoriasis treatment with interferon a", Revue du Rhumatisme 60, 376–377
   Google Scholar
• Kusec, R., Ostrojic, S., Planinc-Peraica, A., Minigo, H. and Jaksic, B. (1990) "Exacerbation of psoriasis after treatment with «-interferon", Dennatologica 181, 170
   PubMedGoogle Scholar
• Makin°, Y, Tanaka, R., Nakamura, K., et al. (1994) "Arthritis in a patient with Ps after interferon a therapy for chronic hepatitis C", J. Rheumatol. 21, 1771–1772
   PubMed Web of Science ®Google Scholar